FJORD MEDICAL AS
Operating
Produsere og selge marine baserte helseprodukter på det internasjonale
markedet. I denne sammenhengen vil selskapet også drive med forskning,
utvikling og innovasjon som relateres til selskapets produkter, og
andre naturlig tilstøtende produkter, herunder å delta i andre
selskaper med lignende virksomhet.
Produktutvikling, produksjon og salg av produkter innen nutraceutical
og medical markedet. Hovedsakelig gjelder dette sluttprodukter som
selges B2B eller B2C, men det kan også være produkter som produseres i
bulk.
Keywords
productionfood productsbreast milk supplementssupplement mixturesmilkbaby foodlow-calorieslimming productsdiet foodmedical purposessodium-freegluten-freenutritional productsathletesdiabetic
Organization
- CEO
- DH
Dag Hjelle1959
- Chairman of the board
- DH
Dag Hjelle1959
- Years since formation
- 5 years
- since Oct 9, 2020
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 200
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Annual total result 2024
- 532
- NOK
- Total equity 2024
- 173,748
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
DH 1959 | Managing Director/CEO | 100 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
DH 1959 | Chairman | 100 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
DH 1959 | Managing Director/CEO, Chairman | 100 % indirectly |
Last update: Dec 4, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 200 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 402,730Operating profit 2024: NOK 71,896Employees: 0
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | 532 | -8,612 | -4,584 | -8,017 |
Total assets | 173,748 | 174,217 | 182,356 | 186,787 |
Total liabilities | 0 | 1,000 | 528 | 375 |
Total equity | 173,748 | 173,217 | 181,828 | 186,412 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 1,123 | 13,019 | 4,966 | 8,017 |
Operating result | -1,123 | -13,019 | -4,966 | -8,017 |
Financial income/costs | 1,655 | 4,407 | 382 | 0 |
Profit before tax | 532 | -8,612 | -4,584 | -8,017 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | 532 | -8,612 | -4,584 | -8,017 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 123,500 | 0 | 0 | 0 |
Total current assets | 50,248 | 174,217 | 182,356 | 186,787 |
Total assets | 173,748 | 174,217 | 182,356 | 186,787 |
Short term debt | 0 | 1,000 | 528 | 375 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 0 | 1,000 | 528 | 375 |
Contributed capital | 194,430 | 194,430 | 194,430 | 194,430 |
Retained earnings | -20,682 | -21,214 | -12,602 | -8,018 |
Total equity | 173,748 | 173,217 | 181,828 | 186,412 |
Total equity and liabilities | 173,748 | 174,217 | 182,356 | 186,787 |
Classification
21st company classification
BETA
Scaleup
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
10
Activity
Manufacture of food products
10.8
Main industrial group
Manufacture of other food products
10.86
Industrial group
Manufacture of homogenised food preparations and dietetic food
10.860
Industrial group
Manufacture of homogenised food preparations and dietetic food